Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Founti, P., Haidich A-B., Chatzikyriakidou A., Salonikiou A., Anastasopoulos E., Pappas T., et al. (2015).  Ethnicity-Based Differences in the Association of LOXL1 Polymorphisms with Pseudoexfoliation/Pseudoexfoliative Glaucoma: A Meta-Analysis.. Ann Hum Genet. 79(6), 431-50.
Founti, P., Topouzis F., van Koolwijk L., Traverso C. E., Pfeiffer N., & Viswanathan A. C. (2009).  Biobanks and the importance of detailed phenotyping: a case study--the European Glaucoma Society GlaucoGENE project.. Br J Ophthalmol. 93(5), 577-81.
Fountoulakis, K. N., Moeller H-J., Kasper S., Tamminga C., Yamawaki S., Kahn R., et al. (2020).  The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia.. CNS Spectr. 1-25.
Fountoulakis, K. N., Gonda X., Andreoulakis E., Fokas K., & Iacovides A. (2013).  No differences between drug naive and drug experienced unipolar depressed patients in terms of neurobiological testing: a cross sectional study.. J Psychiatr Res. 47(12), 1984-90.
Fountoulakis, K. N., & Möller H-J. (2011).  Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.. Int J Neuropsychopharmacol. 14(3), 405-12.
Fountoulakis, K. N., Gonda X., Vieta E., & Schmidt F. (2009).  Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.. Ann Gen Psychiatry. 8, 27.
Fountoulakis, K. N., Karavelas V., Moysidou S., Mavridis D., Pastiadis K., Petalidou N., et al. (2019).  Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study.. Pharmacopsychiatry. 52(4), 193-202.
Fountoulakis, K. N., & Möller H-J. (2012).  Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue.. J Psychopharmacol. 26(5), 744-50.
Fountoulakis, K. N. (2020).  Brain Volume Changes Under Treatment With Antipsychotics.. JAMA Psychiatry. 77(8), 876-877.
Fountoulakis, K. N., Panagiotidis P., Kimiskidis V., Nimatoudis I., & Gonda X. (2019).  Neurological soft signs in familial and sporadic schizophrenia.. Psychiatry Res. 272, 222-229.
Fountoulakis, K. N., Balaris D., Nikolaou V., & Νimatoudis J. (2016).  [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].. Psychiatriki. 27(4), 253-263.
Fountoulakis, K. N. (2017).  DSM-III-R change in definition might have affected placebo response to antidepressants.. Lancet Psychiatry. 4(1), 21-22.
Fountoulakis, K. N., Panagiotidis P., Gonda X., Kimiskidis V., & Nimatoudis I. (2019).  Corrigendum to "Neurological soft signs significantly differentiate schizophrenia patients from healthy controls"; [Acta Neuropsychiatrica 2018;30(2):97-105].. Acta Neuropsychiatr. 31(1), 61.
Fountoulakis, K. N., Siamouli M., Magiria M., Pantoula E., Moutou K., Kemeridou M., et al. (2014).  Standardization of the TEMPS-A in the Greek general population.. J Affect Disord. 158, 19-29.
Fountoulakis, K. N., Yatham L. N., Grunze H., Vieta E., Young A. H., Blier P., et al. (2020).  The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.. Int J Neuropsychopharmacol. 23(4), 230-256.
Fountoulakis, K. N., Panagiotidis P., Theofilidis A. T., & Nimatoudis I. (2020).  One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study.. Clin Psychopharmacol Neurosci. 18(3), 434-444.
Fountoulakis, K. N. (2015).  Treatment guidelines for mental disorders: reality or illusion?. Psychiatriki. 26(2), 89-92.
Fountoulakis, K. N., Savopoulos C., Zannis P., Apostolopoulou M., Fountoukidis I., Kakaletsis N., et al. (2016).  Climate change but not unemployment explains the changing suicidality in Thessaloniki Greece (2000-2012).. J Affect Disord. 193, 331-8.
Fountoulakis, K. N., Pavlidis I., & Tsolaki M. (2011).  Life events and dementia: what is the nature of their relationship?. Psychiatry Res. 190(1), 156-8.
Fountoulakis, K. N. (2012).  Past, present and future in the treatment of major psychotic disorders.. Curr Pharm Des. 18(12), 1557.
Fountoulakis, K. N., & Souliotis K. (2019).  The right to choose treatment-without-treatment: respecting civil rights or an unprecedented manifestation of 'reverse stigma'?. Acta Neuropsychiatr. 31(1), 56-58.
Fountoulakis, K. N., Vieta E., & Schmidt F. (2011).  Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis.. J Affect Disord. 133(3), 361-70.
Fountoulakis, K. N. (2010).  Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'.. Ann Gen Psychiatry. 9, 3.
Fountoulakis, K. N., Koupidis S. A., Grammatikopoulos I. A., & Theodorakis P. N. (2013).  First reliable data suggest a possible increase in suicides in Greece.. BMJ. 347, f4900.
Fountoulakis, K. N., Yatham L., Grunze H., Vieta E., Young A., Blier P., et al. (2017).  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.. Int J Neuropsychopharmacol. 20(2), 121-179.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές